Hypoxia upregulates carcinoembryonic antigen expression in cancer cells
✍ Scribed by Nina Kokkonen; Ines Fernandez Ulibarri; Annika Kauppila; Hanne Luosujärvi; Antti Rivinoja; Helmut Pospiech; Ilmo Kellokumpu; Sakari Kellokumpu
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 333 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Carcinoembryonic antigen (CEA, ceacam5) is an important tumor‐associated antigen with reported roles, e.g., in immunological defense, cell adhesion, cell survival and metastasis. Its overexpression in cancer cells is known to involve transcriptional activation of the CEA gene, but the underlying molecular details remain unclear. Here, we show that hypoxia and intracellular alkalinization, 2 factors commonly found in solid tumors, increase CEA protein expression in breast (MCF‐7) and colorectal (CaCo‐2 and HT‐29) cancer cells. The increase was comparable (2–3‐fold) to that observed in colorectal carcinomas in vivo. CEA promoter analyses further revealed that this upregulation involves a known binding site for HIF‐1 transcription factor (5′‐ACGTG‐3′) within one of the CEA promoter's positive regulatory elements (the FP1 site; the E‐box). Accordingly, deletion or targeted mutagenesis of this motif rendered the CEA promoter unresponsive to hypoxia. Our chromatin immunoprecipitation data confirmed that endogenous HIF‐1α binds to the CEA promoter in hypoxic cells but not in normoxic cells. Moreover, overexpression of the hypoxia‐inducible factor (HIF‐1α) was sufficient to increase CEA protein expression in the cells. In contrast, c‐Myc, which is known to bind to the overlapping E‐box, did not potentiate HIF‐1α‐induced CEA expression. CEA overexpression in vivo was also found to coincide with the expression of carbonic anhydrase IX, a well‐known hypoxia marker. Collectively, these results define CEA as a hypoxia‐inducible protein and suggest an important role for the tumor microenvironmental factors in CEA overexpression during tumorigenesis. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Carcinoembryonic antigen (CEA) levels were determined in 742 postoperative patients with breast cancer. Within this group the percentage of elevated (24.0 ng/ml) assays increased with UICC clinical stage and was 14.8% (12/81), 23.7% (27/114), 73.1% (190/260) and 20.0% (49/245) for stages I, 11, 111,
The expression of carcinoembryonic antigen (CEA) by tumor cells from freshly excised human gastric cancers was investigated using flow cytometry (FCM). Highly purified fresh human cancer cells were obtained from solid tumors in 20 patients and from malignant ascites in 6 patients. Thirteen of the 26
Using a technique of tolerization, a murine monoclonal antibody (MAb 2E8) has been raised which displays regional differences in reactivity in the epithelium of the normal human colon and increased reactivity in active ulcerative colitis. MAb 2ES (IgC,) was highly colon-specific and gave higher immu